These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 15127370
1. Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Low DE. Clin Infect Dis; 2004 May 15; 38 Suppl 4():S357-62. PubMed ID: 15127370 [Abstract] [Full Text] [Related]
2. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. Jones RN, Fritsche TR, Sader HS. Diagn Microbiol Infect Dis; 2005 Jun 15; 52(2):129-33. PubMed ID: 15964501 [Abstract] [Full Text] [Related]
4. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae. Schurek KN, Adam HJ, Hoban DJ, Zhanel GG. Int J Antimicrob Agents; 2006 Sep 15; 28(3):266-9. PubMed ID: 16904294 [Abstract] [Full Text] [Related]
7. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C. J Lab Clin Med; 2004 May 15; 143(5):269-83. PubMed ID: 15122171 [Abstract] [Full Text] [Related]
18. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A. East Mediterr Health J; 2005 Nov 24; 11(1-2):36-44. PubMed ID: 16532669 [Abstract] [Full Text] [Related]
19. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases. Naba MR, Araj GF, Baban TA, Tabbarah ZA, Awar GN, Kanj SS. J Infect Public Health; 2010 Nov 24; 3(3):113-7. PubMed ID: 20869671 [Abstract] [Full Text] [Related]